A Smart Sleep Apnea Self-management Support Programme(4S) for Subjects With Sleep Apnea
1 other identifier
interventional
120
0 countries
N/A
Brief Summary
OSA is a chronic disease with high prevalence that parallels with increasing obesity. Self-management programmes are perceived to be cost-effective in long-term OSA patient care and can supplement regular medical treatments. The current study attempt to examine the effectiveness of 4S on improving apnea severity, cardiovascular health and quality of life in 4S intervention (4S) group, compared to the general hygiene (GH) control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2022
CompletedFirst Posted
Study publicly available on registry
May 25, 2022
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedMay 25, 2022
May 1, 2022
2.3 years
April 21, 2022
May 23, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in apnea hypopnea index
Apnea hypopnea index will be asssessed by sleep test. The apnea hypopnea index is the number of times of apnea or hypopnea during one night, divided by the hours of sleep. The higher the apnea hypopnea index, the more severe sleep apnea is.
Baseline, 4 months
Secondary Outcomes (26)
Change in apnea hypopnea index
Baseline and 12 months
Change in Duration of <90% oxygen desaturation
Baseline, 4 months and 12 months
Change in body weight
Baseline, 4 months and 12 months
Change in body fat
Baseline, 4 months and 12 months
Change in body neck circumference
Baseline, 4 months and 12 months
- +21 more secondary outcomes
Study Arms (2)
Smart Sleep Apnea Self-management Support Programme (4S)
EXPERIMENTALPatients will receive Smart Sleep Apnea Self-management Support Programme (4S) in addition to usual care
General Hygiene Information (GH)
PLACEBO COMPARATORPatients will receive general hygiene information (GH) in addition to usual care
Interventions
The experimental group will receive usual care and Smart Sleep Apnea Self-management Support Programme (4S). The 4S includes two interview sessions, instant messages, phone calls, continuous personalized chat-based messaging and phone call support and hotline services in relation to self-management. An e-platform will be used for self-monitoring and group sharing sessions will be conducted for experience sharing.
The control group will receive usual care and general hygiene information (GH). The GH includes two GH sessions, instant messages, phone calls, continuous personalized chat-based messaging and phone call support and hotline services in relation to general hygiene information. An e-platform will be used for self-monitoring and group sharing sessions will be conducted for experience sharing.
Eligibility Criteria
You may qualify if:
- aged 18 years and above;
- diagnosis of moderate to severe obstructive sleep apnea (AHI≥15);
- physically inactive (self-reported moderate physical activity per week of \<150 minutes);
- overweight (BMI≥23 kg/m2);
- mentally, cognitively and physically fit to join the trial as determined by the doctor in-charge and responsible clinical investigators;
- able to speak and read Chinese;
- willing to complete the questionnaires and assessments;
- has a smartphone with instant messaging function (eg. WhatsApp/WeChat); and
- willing to give informed consent.
You may not qualify if:
- sleep disorder other than OSA;
- clinically significant psychiatric, neurological, or medical disorder other than OSA; and
- use of prescription drugs or clinically significant drugs affecting sleep.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (10)
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pepin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. Epub 2019 Jul 9.
PMID: 31300334BACKGROUNDEpstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009 Jun 15;5(3):263-76.
PMID: 19960649BACKGROUNDAndrade FM, Pedrosa RP. The role of physical exercise in obstructive sleep apnea. J Bras Pneumol. 2016 Nov-Dec;42(6):457-464. doi: 10.1590/S1806-37562016000000156.
PMID: 28117479BACKGROUNDIftikhar IH, Kline CE, Youngstedt SD. Effects of exercise training on sleep apnea: a meta-analysis. Lung. 2014 Feb;192(1):175-84. doi: 10.1007/s00408-013-9511-3.
PMID: 24077936BACKGROUNDAiello KD, Caughey WG, Nelluri B, Sharma A, Mookadam F, Mookadam M. Effect of exercise training on sleep apnea: A systematic review and meta-analysis. Respir Med. 2016 Jul;116:85-92. doi: 10.1016/j.rmed.2016.05.015. Epub 2016 May 21.
PMID: 27296826BACKGROUNDStepnowsky CJ, Palau JJ, Gifford AL, Ancoli-Israel S. A self-management approach to improving continuous positive airway pressure adherence and outcomes. Behav Sleep Med. 2007;5(2):131-46. doi: 10.1080/15402000701190622.
PMID: 17441783BACKGROUNDDickerson SS, Jungquist C, TenBrock E, Aquilina A, Smith P, Sabbah EA, Alameri R, Dean G. Feasibility Testing of a Self-Management Program Book to Improve Adherence to PAP in Persons Newly Diagnosed With Sleep Apnea. Behav Sleep Med. 2018 Sep-Oct;16(5):413-426. doi: 10.1080/15402002.2016.1228644. Epub 2016 Sep 23.
PMID: 27660897BACKGROUNDDickerson SS, TenBrock E, Smith P, Kwon M, Chacko T, Li CS, Dean GE. Mixed methods feasibility study of Breathe2Sleep a peer modeling approach to PAP self-management. Heart Lung. 2020 Nov-Dec;49(6):949-958. doi: 10.1016/j.hrtlng.2020.04.015. Epub 2020 May 28. No abstract available.
PMID: 32473747BACKGROUNDZimbudzi E, Lo C, Misso ML, Ranasinha S, Kerr PG, Teede HJ, Zoungas S. Effectiveness of self-management support interventions for people with comorbid diabetes and chronic kidney disease: a systematic review and meta-analysis. Syst Rev. 2018 Jun 13;7(1):84. doi: 10.1186/s13643-018-0748-z.
PMID: 29898785BACKGROUNDSuarez-Giron M, Garmendia O, Lugo V, Ruiz C, Salord N, Alsina X, Farre R, Montserrat JM, Torres M. Mobile health application to support CPAP therapy in obstructive sleep apnoea: design, feasibility and perspectives. ERJ Open Res. 2020 Feb 10;6(1):00220-2019. doi: 10.1183/23120541.00220-2019. eCollection 2020 Jan.
PMID: 32055630BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnes YK Lai, PhD
The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor did not aware of which groups the patients belongs to.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 21, 2022
First Posted
May 25, 2022
Study Start
June 1, 2022
Primary Completion
September 20, 2024
Study Completion
December 20, 2024
Last Updated
May 25, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- When study finished
- Access Criteria
- The minimal anonymized dataset will be available upon request to interested researchers. For interested researchers, please contact, Mr George Cheung (email ocgeorge@hku.hk), (School of Nursing, The University of Hong Kong) for further information.
Need to obtain consent from patients before agreeing to share individual participants data.